Clinical trial articles often lack detailed descriptions of the methods used to randomize participants, conceal allocation, and blind subjects and investigators to group assignment. We describe our systematic approach to implement and measure blinding success in a double-blind phase 2 randomized controlled trial testing the efficacy of acupuncture for the treatment of vulvodynia.
Methods
Randomization stratified by vulvodynia subtype is managed by Research Electronic Data Capture software’s randomization module adapted to achieve complete masking of group allocation. Subject and acupuncturist blinding assessments are conducted multiple times to identify possible correlates of unblinding.
Results
At present, 48 subjects have been randomized and completed the protocol resulting in 87 subject and 206 acupuncturist blinding assessments.
Discussion
Our approach to blinding and blinding assessment has the potential to improve our understanding of unblinding over time in the presence of possible clinical improvement.
BornsteinJGoldsteinATStockdaleCK, et al. 2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. J Sex Med2016; 13(4): 607–612.
2.
VickersAJVertosickEALewithG, et al. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain2018; 19(5): 455–474.
3.
BausellRLaoLBergmanS, et al. Is acupuncture analygesia an expectancy effect?Eval Health Prof2005; 28: 9–26.
4.
McGeeneyBE. Acupuncture is all placebo and here is why. Headache2015; 55(3): 465–469.
5.
ColquhounDNovellaSP. Acupuncture is theatrical placebo. Anesth Analg2013; 116(6): 1360–1363.
6.
KimTHLeeMSAlraekT, et al. Acupuncture in sham device controlled trials may not be as effective as acupuncture in the real world: a preliminary network meta-analysis of studies of acupuncture for hot flashes in menopausal women. Acupunct Med2020; 38(1): 37–44.
7.
TakakuraNYajimaH. A double-blind placebo needle for acupuncture research. BMC Complement Altern Med2007; 7: 31.
8.
TakakuraNTakayamaMKawaseA, et al. Double-blind acupuncture needle: a potential tool to investigate the nature of pain and pleasure. ISRN Pain2013; 2013: 825751.
9.
TakakuraNTakayamaMKawaseA, et al. Double-blind acupuncture needling: does patient reaction reveal needle authenticity?Med Acupunct2008; 20(3): 169–174.
10.
TakakuraNTakayamaMKawaseA, et al. Double blinding with a new placebo needle: a validation study on participant blinding. Acupunct Med2011; 29(3): 203–207.
11.
TakakuraNYajimaH. A placebo acupuncture needle with potential for double blinding: a validation study. Acupunct Med2008; 26(4): 224–230.
12.
TakakuraNYajimaH. Analgesic effect of acupuncture needle penetration: a double-blind crossover study. Open Med2009; 3(2): e54–e61.
MoherDHopewellSSchulzKF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ2010; 340: c869.
15.
PolitDF. Blinding during the analysis of research data. Int J Nurs Stud2011; 48(5): 636–641.
16.
PolitDFGillespieBMGriffinR. Deliberate ignorance: a systematic review of blinding in nursing clinical trials. Nurs Res2011; 60(1): 9–16.
17.
SackettDL. Commentary: measuring the success of blinding in RCTs: don’t, must, can’t or needn’t?Int J Epidemiol2007; 36(3): 664–665.
18.
KolahiJBangHParkJ. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. Community Dent Oral Epidemiol2009; 37(6): 477–484.
19.
SchulzKFAltmanDGMoherD, et al. CONSORT 2010 changes and testing blindness in RCTs. Lancet2010; 375(9721): 1144–1146.
20.
HarrisPATaylorRMinorBL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform2019; 95: 103208.
21.
HarrisPATaylorRThielkeR, et al. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform2009; 42(2): 377–381.
22.
HarlowBLStewartEG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia?J Am Med Womens Assoc2003; 58(2): 82–88.
23.
Stata statistical software: release 15 (computer program). College Station, TX: StataCorp, 2017.
24.
BangHJNiLYDavisCE. Assessment of blinding in clinical trials. Control Clin Trials2004; 25(2): 143–156.
25.
MorozAFreedBTiedemannL, et al. Blinding measured: a systematic review of randomized controlled trials of acupuncture. Evid Based Complement Alternat Med2013; 2013: 708251.
26.
FreedBAssallOPPanagiotakisG, et al. Assessing blinding in trials of psychiatric disorders: a meta-analysis based on blinding index. Psychiatry Res2014; 219(2): 241–247.
27.
HedekerDGibbonsRD. Longitudinal data analysis. Hoboken, NJ: John Wiley & Sons, 2006.
28.
EndersCK. Applied missing data analysis. New York: Guilford Press, 2010.
29.
GrahamJW. Missing data analysis: making it work in the real world. Annu Rev Psychol2009; 60: 549–576.
30.
BangH. Random guess and wishful thinking are the best blinding scenarios. Contemp Clin Trials Commun2016; 3: 117–121.
31.
BangHParkJJ. Blinding in clinical trials: a practical approach. J Altern Complement Med2013; 19(4): 367–369.
32.
BangHJNiLYDavisCE. Assessment of blinding may be inappropriate after the trial: response to Henneicke-von-Zepelin and Harri Hemili’s comment. Contemp Clin Trials2005; 26(4): 514–515.
33.
ParkJBangHCañetteI. Blinding in clinical trials, time to do it better. Complement Ther Med2008; 16(3): 121–123.
34.
ArandjelovićO. A new framework for interpreting the outcomes of imperfectly blinded controlled clinical trials. PLoS ONE2012; 7(12): e48984.
35.
ChowSCShaoJ. Analysis of clinical data with breached blindness. Stat Med2004; 23(8): 1185–1193.
